Soleno Therapeutics (SLNO) Short term Debt (2013 - 2015)

Soleno Therapeutics (SLNO) has 3 years of Short term Debt data on file, last reported at $865000.0 in Q4 2015.

• Short term Debt for Q4 2015 came in at $865000.0, up 751.97% year-over-year; the trailing twelve-month figure through Dec 2015 was $865000.0 (up 751.97% YoY), and the FY2015 annual result was $865000.0, up 751.97% from the prior year.
• Short term Debt eased to $865000.0 in Q4 2015 per SLNO's latest filing, from $3.9 million in the prior quarter.
• Over five years, Short term Debt peaked at $14.0 million in Q4 2013 and troughed at $101529.0 in Q4 2014.
• A 3-year average of $6.0 million and a median of $3.9 million in 2015 frame the typical range for Short term Debt.
• The sharpest annual moves came in 2014 and 2015: Short term Debt plunged 99.27% in 2014, then soared 751.97% in 2015.
• A 3-year view of Short term Debt shows it stood at $14.0 million in 2013, then sank by 99.27% to $101529.0 in 2014, then soared by 751.97% to $865000.0 in 2015.
• Business Quant data shows SLNO's Short term Debt at $865000.0 in Q4 2015, $3.9 million in Q3 2015, and $11.0 million in Q2 2015.